Strategies for implementing an ePRO-based symptom management program (eSyM) across six cancer centers.

Authors

null

Michael J. Hassett

Dana-Farber Cancer Institute, Boston, MA

Michael J. Hassett , Christine Cronin , Nadine Jackson McCleary , Jessica J Bian , Sandra L. Wong , Hannah W. Hazard-Jenkins , Samira Dias , Julie Johnson , Deborah Schrag , Don S. Dizon , Raymond U. Osarogiagbon

Organizations

Dana-Farber Cancer Institute, Boston, MA, Dana Farber Cancer Institute, Boston, MA, Brown University, Providence, RI, University of Michigan Health System, Ann Arbor, MI, West Virginia University, Morgantown, WV, Lifespan Cancer Institute and Brown University, Providence, RI, Multidisciplinary Thoracic Oncology Department, Baptist Cancer Center, Memphis, TN

Research Funding

U.S. National Institutes of Health

Background: Electronic patient-reported outcome (ePRO)-based symptom management can improve cancer care outcomes. However, implementation is challenging as it requires 1) tremendous technical resources to integrate ePROs into the electronic health record (EHR), 2) substantial buy-in from clinicians and patients, 3) between visit symptom management, and 4) institutional investment to support engagement. Methods: The SIMPRO Consortium developed and deployed eSyM, an EHR-integrated ePRO-based symptom management program for medical oncology and surgery patients, at 6 cancer centers between September 2019-March 2022. Site teams document new and changes to implementation strategies monthly using REDCap (data collection is ongoing). Strategies are itemized using the Expert Recommendations for Implementation Change (ERIC) list and mapped to the Consolidated Framework for Implementation Research (CFIR) list of barriers. The SIMPRO Coordinating Center (Dana-Farber) reviews all ERIC-CFIR classifications for consistency. Results: To date, 162 distinct strategies have been documented. On average, sites have implemented 23 strategies, 5 preparing for go-live and 18 remaining active beyond go-live. Preparation of clinical staff, training, and routine program evaluation are consistent high impact strategies. Other adaptive strategies have varied across sites, including various approaches to patient and provider engagement. Foundational strategies have been deployed by the coordinating center to support the multi-center initiative. Conclusions: Methodical deployment using theory-based implementation strategies may foster adoption of novel health care delivery systems by patients, clinicians, and institutions. Attention to the specific high-value strategies identified by the SIMPRO Consortium could support similar ePRO deployment at other institutions.

Strategy Type
ERIC Category
CFIR Domain (Construct)
Example
High-Impact

(Universal)
Develop & implement quality monitoring tools
Process (reflect & evaluate)
Automated reports to capture usage rates
Conduct educational meetings
Process (engage)
Training sessions with clinicians
Purposefully reexamine the implementation
Characteristics of individuals (knowledge & beliefs about the intervention)
Meetings with stakeholders
Adaptive

(Site-Specific)
Prepare patients to be active participants
Process (execute)
Phone calls, portal messages, and/or in-person approaches to assist patients
Foundational

(Consortium-Wide)
Obtain & use patient/consumer feedback
Intervention characteristics (adaptability)
Modify questionnaires & alerts
Create a learning collaborative
Outer setting (cosmopolitanism)
Monthly consortium meetings
Assess for readiness; identify facilitators & barriers
Inner setting (implementation climate)
Stakeholder assessments pre and post go-live

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Health Promotion/Behaviors

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 12017)

DOI

10.1200/JCO.2022.40.16_suppl.12017

Abstract #

12017

Poster Bd #

263

Abstract Disclosures